Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/24/2024Review of Leading Class 1 New Drugs by Chinese Sales Value in 2023
  • 4/24/2024NHC Issues Announcement on Jurisdiction of Human Genetic Resource Mana...
  • 4/23/2024Novartis Actively Evaluating Ties with Chinese Contractors Amidst US B...
  • 4/23/2024NMPA Issues Announcement on Further Strengthening the Drug Distributio...
  • 4/23/2024NMPA Issues the Announcement on Relevant Matters Concerning the Optimi...
  • 4/19/2024Drug R&D and Product Registration News Digest April 2024 (3)
  • 4/19/2024Recent Executive Moves
  • 4/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (81...
  • 4/18/2024CDE Issues the Detailed Rules on Adding Pediatric Information to the P...
  • 4/18/2024Andao Pharma/Kind Pharma and Fibrogen Settle on IP Dispute over HIF- P...
  • 4/17/2024China Announces the 2024 Special Rectification Plan for Illegal Activi...
  • 4/17/2024NMPA Withdraws Approvals for 87 Drug Products
  • 4/16/2024NMPA Issues the List of Reference Formulations for GQCE Studies (79th ...
  • 4/15/2024NHC Issues the Guidelines for the Diagnosis and Treatment of Primary L...
  • 4/15/2024NHSA: Over 11M Chinese Benefited from Critical Illness Insurance
  • 4/12/2024Drug R&D and Product Registration News Digest April 2024 (2)
  • 4/12/2024Recent Executive Moves
  • 4/12/2024Review of Chinese Online Pharmacy Drug Sales and Leading Products in 2...
  • 4/12/2024PhIIC: Review of Chinese Hospital Drug Market in 2023
  • 4/12/2024Whooping Cough Resurges in Post-Pandemic China
  • 4/11/2024Out-of-Area Medical Bill Settlement Jumps Nearly Fourfold After BMI S...
  • 4/11/2024NHSA Disputes Claims of a 'Dropout Wave' in China's Basic Medical Insu...
  • 4/11/2024NHSA's 2023 Healthcare Security Sector Development Statistical Highlig...
  • 4/11/2024CDE Issues the Summary of Bioequivalence Studies for Generic Drugs
  • 4/10/2024Review of Class 1 New Drug R&D in China 2018-2023
  • 4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018
  • 4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023
  • 4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...
  • 4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules
  • 4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...
  • Page:1/32 Total number of articles:951: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group